Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

MUC5B Promoter Polymorphism and Development of ARDS.

Rogers AJ, Solus JF, Hunninghake GM, Baron RM, Meyer NJ, Janz DR, Schwartz DA, May AK, Lawson WE, Blackwell TS, Ware LB.

Am J Respir Crit Care Med. 2018 Jul 19. doi: 10.1164/rccm.201801-0140LE. [Epub ahead of print] No abstract available.

PMID:
30025215
2.

Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis.

Carranza-Leon D, Octaria R, Ormseth MJ, Oeser A, Solus JF, Zhang Y, Okafor CR, Titze J, Michael Stein C, Chung CP.

Clin Rheumatol. 2018 Apr;37(4):895-900. doi: 10.1007/s10067-017-3935-8. Epub 2017 Dec 14.

PMID:
29243056
3.

Generalized pustular drug eruption caused by topical 5-fluorouracil.

Nemer KM, Solus JF, Schaffer A, Rosman IS, Lee SJ.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12520. Epub 2017 Aug 18. No abstract available.

PMID:
28834062
4.

Telomere Length and Coronary Atherosclerosis in Rheumatoid Arthritis.

Ormseth MJ, Solus JF, Oeser AM, Bian A, Gebretsadik T, Shintani A, Raggi P, Stein CM.

J Rheumatol. 2016 Aug;43(8):1469-74. doi: 10.3899/jrheum.151115. Epub 2016 Jun 1.

5.

Pleomorphic soft tissue sarcoma metastatic to the skin of the scalp and groin.

Staser K, Mount CE 3rd, Solus J, Musiek A.

JAAD Case Rep. 2015 Mar 27;1(2):96-8. doi: 10.1016/j.jdcr.2015.02.005. eCollection 2015 Mar. No abstract available.

6.

Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.

Ormseth MJ, Yancey PG, Solus JF, Bridges SL Jr, Curtis JR, Linton MF, Fazio S, Davies SS, Roberts LJ 2nd, Vickers KC, Kon V, Michael Stein C; TETRAD Investigators.

Arthritis Rheumatol. 2016 Sep;68(9):2099-105. doi: 10.1002/art.39675.

7.

Cytokeratin 17 is highly sensitive in discriminating cutaneous lymphadenoma (a distinct trichoblastoma variant) from basal cell carcinoma.

Goyal A, Solus JF, Chan MP, Doyle LA, Schaffer A, Thakuria M, Horn TD, Duncan LM, Nazarian RM.

J Cutan Pathol. 2016 May;43(5):422-9. doi: 10.1111/cup.12700. Epub 2016 Apr 6.

PMID:
26968559
8.

Extensive tumoral melanosis associated with ipilimumab-treated melanoma.

Staser K, Chen D, Solus J, Rosman IS, Schaffer A, Cornelius L, Linette GP, Fields RC.

Br J Dermatol. 2016 Aug;175(2):391-3. doi: 10.1111/bjd.14474. Epub 2016 Mar 18.

PMID:
26877232
9.

Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining.

Solus JF, Hassan K, Lee SJ, Hsi AC, Rosman IS, Dehmeri S, Schaffer A.

J Cutan Pathol. 2016 Apr;43(4):347-53. doi: 10.1111/cup.12667. Epub 2016 Feb 10.

PMID:
26762870
10.

GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.

Chung CP, Ormseth MJ, Connelly MA, Oeser A, Solus JF, Otvos JD, Raggi P, Stein CM.

Lupus. 2016 Mar;25(3):296-300. doi: 10.1177/0961203315617842. Epub 2015 Dec 3.

11.

Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and histopathologic findings.

Mull JL, Solus JF, Mutizwa MM, Chiang HC, Rosman IS, Musiek A.

Dermatol Online J. 2015 Aug 15;21(8). pii: 13030/qt3v22b88d.

PMID:
26437163
12.

Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features.

Solus JF, Murphy GF, Kraft S.

Int J Surg Pathol. 2016 Feb;24(1):29-36. doi: 10.1177/1066896915599058. Epub 2015 Aug 10.

PMID:
26261102
13.

Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.

Ormseth MJ, Solus JF, Vickers KC, Oeser AM, Raggi P, Stein CM.

J Rheumatol. 2015 Oct;42(10):1746-1751. doi: 10.3899/jrheum.150232. Epub 2015 Aug 1.

14.

Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.

Ormseth MJ, Chung CP, Oeser AM, Connelly MA, Sokka T, Raggi P, Solus JF, Otvos JD, Stein CM.

Arthritis Res Ther. 2015 May 9;17:117. doi: 10.1186/s13075-015-0646-x.

15.

Comparison of resident and glaucoma faculty practice patterns in the care of open-angle glaucoma.

Zebardast N, Solus JF, Quigley HA, Srikumaran D, Ramulu PY.

BMC Ophthalmol. 2015 Apr 14;15:41. doi: 10.1186/s12886-015-0027-x.

16.

A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study.

Chung CP, Solus JF, Oeser A, Li C, Raggi P, Smith JR, Stein CM.

Int J Mol Sci. 2015 Feb 11;16(2):3885-94. doi: 10.3390/ijms16023885.

17.

Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.

Solus JF, Chung CP, Oeser A, Li C, Rho YH, Bradley KM, Kawai VK, Smith JR, Stein CM.

Clin Rheumatol. 2015 Aug;34(8):1375-82. doi: 10.1007/s10067-015-2881-6. Epub 2015 Feb 5.

18.

Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness.

Becetti K, Oeser A, Ormseth MJ, Solus JF, Raggi P, Stein CM, Chung CP.

J Rheumatol. 2015 Apr;42(4):593-8. doi: 10.3899/jrheum.141295. Epub 2015 Feb 1.

19.

Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation.

Darghosian L, Free M, Li J, Gebretsadik T, Bian A, Shintani A, McBride BF, Solus J, Milne G, Crossley GH, Thompson D, Vidaillet H, Okafor H, Darbar D, Murray KT, Stein CM.

Am J Cardiol. 2015 Jan 15;115(2):196-201. doi: 10.1016/j.amjcard.2014.10.022. Epub 2014 Oct 29.

20.

Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

Kropski JA, Pritchett JM, Zoz DF, Crossno PF, Markin C, Garnett ET, Degryse AL, Mitchell DB, Polosukhin VV, Rickman OB, Choi L, Cheng DS, McConaha ME, Jones BR, Gleaves LA, McMahon FB, Worrell JA, Solus JF, Ware LB, Lee JW, Massion PP, Zaynagetdinov R, White ES, Kurtis JD, Johnson JE, Groshong SD, Lancaster LH, Young LR, Steele MP, Phillips Iii JA, Cogan JD, Loyd JE, Lawson WE, Blackwell TS.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):417-26. doi: 10.1164/rccm.201406-1162OC.

22.

Basaloid Carcinoma of the Breast Mimicking Cutaneous Basaloid Neoplasms.

Solus JF, Goyal A, Duncan LM, Nazarian RM.

Am J Dermatopathol. 2015 Sep;37(9):e102-6. doi: 10.1097/DAD.0000000000000209.

PMID:
25229570
23.

Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12.

Orbelyan GA, Tang F, Sally B, Solus J, Meresse B, Ciszewski C, Grenier JC, Barreiro LB, Lanier LL, Jabri B.

J Immunol. 2014 Jul 15;193(2):610-6. doi: 10.4049/jimmunol.1400556. Epub 2014 Jun 16.

24.

Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy.

Ormseth MJ, Oeser AM, Cunningham A, Bian A, Shintani A, Solus J, Tanner SB, Stein CM.

Arthritis Rheumatol. 2014 Sep;66(9):2331-8. doi: 10.1002/art.38686.

25.

Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus.

Chung CP, Solus JF, Oeser A, Li C, Raggi P, Smith JR, Stein CM.

Lupus. 2014 Aug;23(9):876-80. doi: 10.1177/0961203314530019. Epub 2014 Apr 3.

26.

Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.

Bradham WS, Ormseth MJ, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM.

Inflammation. 2014 Jun;37(3):801-8. doi: 10.1007/s10753-013-9799-4.

27.

Risk factors for adverse consequences of low intraocular pressure after trabeculectomy.

Saeedi OJ, Jefferys JL, Solus JF, Jampel HD, Quigley HA.

J Glaucoma. 2014 Jan;23(1):e60-8. doi: 10.1097/IJG.0000000000000008.

PMID:
24145291
28.

Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome.

Kawai VK, Avalos I, Oeser A, Oates JA, Milne GL, Solus JF, Chung CP, Stein CM.

Arthritis Care Res (Hoboken). 2014 Feb;66(2):285-92. doi: 10.1002/acr.22169.

29.

Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.

Ormseth MJ, Oeser AM, Cunningham A, Bian A, Shintani A, Solus J, Tanner S, Stein CM.

Arthritis Res Ther. 2013;15(5):R110.

30.

Inflammation and hypertension in rheumatoid arthritis.

Manavathongchai S, Bian A, Rho YH, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM.

J Rheumatol. 2013 Nov;40(11):1806-11. doi: 10.3899/jrheum.130394. Epub 2013 Sep 1.

31.

Ras, Raf, and MAP kinase in melanoma.

Solus JF, Kraft S.

Adv Anat Pathol. 2013 Jul;20(4):217-26. doi: 10.1097/PAP.0b013e3182976c94. Review.

PMID:
23752084
33.

Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.

Ormseth MJ, Swift LL, Fazio S, Linton MF, Raggi P, Solus JF, Oeser A, Bian A, Gebretsadik T, Shintani A, Stein CM.

Lupus. 2013 Jan;22(1):26-33. doi: 10.1177/0961203312462756. Epub 2012 Oct 11.

34.

High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation.

Bradham WS, Bian A, Oeser A, Gebretsadik T, Shintani A, Solus J, Estis J, Lu QA, Todd J, Raggi P, Stein CM.

PLoS One. 2012;7(6):e38930. doi: 10.1371/journal.pone.0038930. Epub 2012 Jun 28.

35.

Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.

Ghimire LV, Kohli U, Li C, Sofowora GG, Muszkat M, Friedman EA, Solus JF, Wood AJ, Stein CM, Kurnik D.

Pharmacogenet Genomics. 2012 Apr;22(4):254-60. doi: 10.1097/FPC.0b013e328350a274.

36.

Outcomes and bleb-related complications of trabeculectomy.

Jampel HD, Solus JF, Tracey PA, Gilbert DL, Loyd TL, Jefferys JL, Quigley HA.

Ophthalmology. 2012 Apr;119(4):712-22. doi: 10.1016/j.ophtha.2011.09.049. Epub 2012 Jan 14.

PMID:
22244944
37.

Comparison of limbus-based and fornix-based trabeculectomy: success, bleb-related complications, and bleb morphology.

Solus JF, Jampel HD, Tracey PA, Gilbert DL, Loyd TL, Jefferys JL, Quigley HA.

Ophthalmology. 2012 Apr;119(4):703-11. doi: 10.1016/j.ophtha.2011.09.046. Epub 2012 Jan 9.

PMID:
22226886
38.

Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.

Lertnawapan R, Bian A, Rho YH, Raggi P, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM.

Lupus. 2012 Mar;21(3):279-87. doi: 10.1177/0961203311425527. Epub 2011 Nov 9.

39.

Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus.

Kawai VK, Solus JF, Oeser A, Rho YH, Raggi P, Bian A, Gebretsadik T, Shintani A, Stein CM.

Lupus. 2011 Dec;20(14):1526-34. doi: 10.1177/0961203311420317. Epub 2011 Oct 5.

40.

Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis.

Ormseth MJ, Swift LL, Fazio S, Linton MF, Chung CP, Raggi P, Rho YH, Solus J, Oeser A, Bian A, Gebretsadik T, Shintani A, Stein CM.

Atherosclerosis. 2011 Dec;219(2):869-74. doi: 10.1016/j.atherosclerosis.2011.09.005. Epub 2011 Sep 12.

41.

Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis.

Lertnawapan R, Bian A, Rho YH, Kawai VK, Raggi P, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM.

J Rheumatol. 2011 Nov;38(11):2297-300. doi: 10.3899/jrheum.110168. Epub 2011 Aug 15.

42.

Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.

Rho YH, Solus J, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM.

Arthritis Care Res (Hoboken). 2011 Apr;63(4):535-41. doi: 10.1002/acr.20365.

43.

Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.

Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF, Linton MF, Fazio S, Stein CM.

J Rheumatol. 2010 Aug 1;37(8):1633-8. doi: 10.3899/jrheum.090639. Epub 2010 Jun 1.

44.

Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.

Rho YH, Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Raggi P, Milne GL, Stein CM.

Arthritis Care Res (Hoboken). 2010 Oct;62(10):1473-80. doi: 10.1002/acr.20237.

45.

Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.

Rho YH, Chung CP, Solus JF, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM.

Arthritis Rheum. 2010 May;62(5):1259-64. doi: 10.1002/art.27376.

46.

Role of inflammation and oxidative stress in atrial fibrillation.

Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D.

Heart Rhythm. 2010 Apr;7(4):438-44. doi: 10.1016/j.hrthm.2009.12.009. Epub 2009 Dec 24.

47.

Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.

Muszkat M, Kurnik D, Sofowora GG, Solus J, Xie HG, Harris PA, Williams SM, Wood AJ, Stein CM.

J Hypertens. 2010 Feb;28(2):278-84. doi: 10.1097/HJH.0b013e328333d212.

48.

Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.

Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T, Raggi P, Gebretsadik T, Shintani A, Stein CM.

Arthritis Rheum. 2009 Nov 15;61(11):1580-5. doi: 10.1002/art.25009.

49.

Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.

Chung CP, Long AG, Solus JF, Rho YH, Oeser A, Raggi P, Stein CM.

Lupus. 2009 Aug;18(9):799-806. doi: 10.1177/0961203309103582.

50.

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM.

Arthritis Rheum. 2009 Jul;60(7):1906-14. doi: 10.1002/art.24626.

Supplemental Content

Support Center